Phase 3 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have active ulcerative colitis that is considered moderate to severe (based on a scoring system called the Mayo score, with a result above 6)
- You have previously used or are currently using a medication called 5-ASA (a common treatment for bowel inflammation) safely
- You are able to have an endoscopy (a camera examination of the inside of your bowel)
Who may not be able to join:
- You have taken antibiotics in the last 7 days
- You are considered at high risk of a serious bowel complication called toxic megacolon (a dangerous swelling of the large intestine — confirm with trial site)
- You have been found to have colon cancer or abnormal growths in your bowel
- You have another serious illness affecting your heart, lungs, digestive system, or kidneys
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yuqiang Nie, MD, Guangzhou First People's Hospital
Phone: 86-13631316718
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical remission in patient as assessed using Mayo score; Clinical improvement in patient as assessed using Mayo score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.